AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 84 filers reported holding AMRYT PHARMA PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $91,534,479 | +98.0% | 6,278,085 | -0.9% | 30.70% | +57.8% |
| Q4 2022 | $46,232,645 | +7.3% | 6,333,239 | +1.7% | 19.45% | +0.4% |
| Q3 2022 | $43,096,000 | -2.1% | 6,227,733 | -1.1% | 19.37% | -5.4% |
| Q2 2022 | $44,025,000 | -16.0% | 6,298,348 | -0.6% | 20.48% | -5.8% |
| Q1 2022 | $52,417,000 | -20.0% | 6,338,200 | +4.4% | 21.74% | -27.7% |
| Q4 2021 | $65,554,000 | -6.2% | 6,069,775 | +4.6% | 30.08% | -5.4% |
| Q3 2021 | $69,882,000 | +105.9% | 5,801,748 | +107.4% | 31.80% | +79.2% |
| Q2 2021 | $33,937,000 | -3.5% | 2,797,744 | +10.9% | 17.75% | -6.6% |
| Q1 2021 | $35,156,000 | +75.3% | 2,523,728 | +78.2% | 18.99% | +23.7% |
| Q4 2020 | $20,057,000 | +112.1% | 1,416,483 | +85.1% | 15.36% | +56.1% |
| Q3 2020 | $9,458,000 | – | 765,236 | – | 9.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $61,912,000 | 26.04% |
| Stonepine Capital Management, LLC | 6,298,348 | $44,025,000 | 20.48% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $18,655,000 | 7.87% |
| Aquilo Capital Management, LLC | 1,866,652 | $13,048,000 | 4.45% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,144,000 | 2.04% |
| Global Frontier Investments LLC | 435,000 | $3,040,000 | 1.42% |
| Rubric Capital Management LP | 3,600,000 | $25,164,000 | 1.32% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $44,272,000 | 1.01% |
| Telemetry Investments, L.L.C. | 121,670 | $850,000 | 1.01% |
| Clearline Capital LP | 631,942 | $4,417,000 | 0.57% |